SG10202011339RA - Microrna biomarker for the diagnosis of gastric cancer - Google Patents
Microrna biomarker for the diagnosis of gastric cancerInfo
- Publication number
- SG10202011339RA SG10202011339RA SG10202011339RA SG10202011339RA SG10202011339RA SG 10202011339R A SG10202011339R A SG 10202011339RA SG 10202011339R A SG10202011339R A SG 10202011339RA SG 10202011339R A SG10202011339R A SG 10202011339RA SG 10202011339R A SG10202011339R A SG 10202011339RA
- Authority
- SG
- Singapore
- Prior art keywords
- diagnosis
- gastric cancer
- microrna biomarker
- microrna
- biomarker
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SG10201404742W | 2014-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202011339RA true SG10202011339RA (en) | 2020-12-30 |
Family
ID=55264222
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202011339RA SG10202011339RA (en) | 2014-08-07 | 2015-08-11 | Microrna biomarker for the diagnosis of gastric cancer |
| SG11201700944RA SG11201700944RA (en) | 2014-08-07 | 2015-08-11 | Microrna biomarker for the diagnosis of gastric cancer |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700944RA SG11201700944RA (en) | 2014-08-07 | 2015-08-11 | Microrna biomarker for the diagnosis of gastric cancer |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10767230B2 (enExample) |
| EP (3) | EP3177739B1 (enExample) |
| JP (3) | JP6702935B2 (enExample) |
| KR (2) | KR102604163B1 (enExample) |
| CN (1) | CN107109470B (enExample) |
| SG (2) | SG10202011339RA (enExample) |
| WO (1) | WO2016022076A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3177739B1 (en) * | 2014-08-07 | 2019-10-23 | Agency For Science, Technology And Research | Microrna biomarker for the diagnosis of gastric cancer |
| CN107683341A (zh) * | 2015-05-08 | 2018-02-09 | 新加坡科技研究局 | 用于慢性心力衰竭的诊断和预后的方法 |
| CN106636334B (zh) * | 2016-10-09 | 2020-07-03 | 山东大学 | microRNA标志物组及其在制备检测胃癌淋巴结转移试剂盒中的应用 |
| JP6280997B1 (ja) * | 2016-10-31 | 2018-02-14 | 株式会社Preferred Networks | 疾患の罹患判定装置、疾患の罹患判定方法、疾患の特徴抽出装置及び疾患の特徴抽出方法 |
| CN106755377B (zh) * | 2016-12-12 | 2021-05-25 | 浙江省中医院 | 一种胃癌血清学检测鉴定试剂盒及方法 |
| CA3057322A1 (en) * | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Method for diagnosing or monitoring conditions characterized by abnormal temporal variations and method of normalizing epigenetic data to compensate for temporal variations |
| CL2017002289A1 (es) | 2017-09-08 | 2019-08-16 | Univ Pontificia Catolica Chile | Método no invasivo de diagnóstico temprano de cáncer gástrico, usando como biomarcador los niveles de metilación de la secuencia de adn del promotor del microrna -335-5p |
| CN107723366B (zh) * | 2017-09-11 | 2019-10-01 | 朱伟 | 一种与贲门癌辅助诊断相关的血清miRNA标志物及其应用 |
| CN107746880B (zh) * | 2017-11-01 | 2018-12-14 | 健生生物技术有限公司 | 一种基于RT-qPCR法检测胃癌的试剂盒及其制备方法和应用 |
| CN108611414A (zh) * | 2018-04-26 | 2018-10-02 | 北京工业大学 | 新的靶向肿瘤微环境与肺癌干细胞相互作用的miRNA的检测及应用 |
| CN108743617A (zh) * | 2018-05-03 | 2018-11-06 | 武汉科技大学 | miR-15a-5p在提高CAR-T细胞抗肿瘤能力中的应用 |
| JP7345860B2 (ja) * | 2018-06-21 | 2023-09-19 | 公立大学法人名古屋市立大学 | 胃癌バイオマーカー及びその用途 |
| KR102089559B1 (ko) * | 2018-08-31 | 2020-03-16 | 차의과학대학교 산학협력단 | 난소의 fsh에 대한 반응성의 진단 또는 예측용 바이오마커 및 이의 용도 |
| TW202018727A (zh) | 2018-11-09 | 2020-05-16 | 財團法人工業技術研究院 | 整體式學習預測方法與系統 |
| EP3899052A4 (en) * | 2018-12-19 | 2023-02-22 | Agency For Science, Technology And Research | PROCESS |
| WO2020132494A2 (en) * | 2018-12-21 | 2020-06-25 | Baylor Research Institute | Methods for prognosing, diagnosing, and treating gastric cancer |
| CN110066870B (zh) * | 2019-04-12 | 2021-12-14 | 江苏省人民医院（南京医科大学第一附属医院） | hsa-miR-382-5p在制备诊断视网膜变性疾病的试剂盒中的应用 |
| CN117683886A (zh) * | 2019-04-30 | 2024-03-12 | 觅瑞实验室私人有限公司 | 一种检测胃癌的miRNA标志物组合及试剂盒 |
| KR102288359B1 (ko) * | 2019-12-06 | 2021-08-10 | 주식회사 레피겐엠디 | 면역력 감소에 의한 질병의 발병 위험 예측용 다중 유전자 마커 및 이를 이용한 질병의 발병 위험 예측 방법 |
| CN111471764B (zh) * | 2019-12-27 | 2023-09-15 | 陈锦飞 | 一种用于筛查或辅助诊断胃癌的生物标志物组合及其试剂盒和应用 |
| WO2021149719A1 (ja) * | 2020-01-24 | 2021-07-29 | アルプスアルパイン株式会社 | ｍｉＲＮＡの発現レベルをがんの指標として用いる方法 |
| CN111471683B (zh) * | 2020-04-15 | 2021-09-07 | 湖南省科域生物医药科技有限公司 | miR-93-5p作为诊断和治疗胃癌标志物的应用 |
| KR102489708B1 (ko) * | 2020-09-14 | 2023-01-18 | 서울대학교산학협력단 | GDF11 유전자의 발현을 조절하는 PCBP2와 microRNA를 함유하는 조성물 |
| CN112226514B (zh) * | 2020-11-23 | 2021-08-03 | 苏州京脉生物科技有限公司 | 用于早期胃癌检测的标志物组合、试剂盒及其应用 |
| CN112941185B (zh) * | 2021-03-26 | 2023-06-23 | 杭州医学院 | miR-29a作为标志物在制备恶性间皮瘤检测试剂盒中的应用 |
| CN113151477B (zh) * | 2021-05-08 | 2022-04-15 | 武汉大学中南医院 | 用于检测肠癌的miRNA标记物及其应用 |
| CN113186285B (zh) * | 2021-05-10 | 2022-05-24 | 深圳市展行生物有限公司 | 一种辅助诊断胃癌的方法及其使用的miRNA组合 |
| CN113913516B (zh) * | 2021-05-26 | 2023-08-29 | 东莞市松山湖中心医院(东莞市石龙人民医院、东莞市第三人民医院、东莞市心血管病研究所) | hsa_circ_0006470作为靶点在制备miR-27b-3p的调节剂的应用 |
| JP7406059B1 (ja) | 2022-10-20 | 2023-12-27 | 防衛装備庁長官 | 急性ストレス評価用データの生成方法 |
| WO2024229279A2 (en) * | 2023-05-02 | 2024-11-07 | Dana-Farber Cancer Institute, Inc. | Use of circulating microrna profiles for identification of brca1 or brca2 mutations |
| CN118547069B (zh) * | 2024-05-14 | 2025-08-22 | 北京热景生物技术股份有限公司 | 一种基于细胞外囊泡miRNA的胃癌诊断标志物及其应用 |
| CN119580829A (zh) * | 2024-11-25 | 2025-03-07 | 苏州大学 | 一种早期胃癌检测的标志物识别方法及诊断模型构建方法 |
| CN119351558A (zh) * | 2024-12-10 | 2025-01-24 | 西藏自治区人民政府驻成都办事处医院 | 一种检测胃癌的标志物、检测试剂盒及药物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013245505B2 (en) * | 2006-01-05 | 2016-06-23 | The Ohio State University Research Foundation | MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers |
| ES2508893T3 (es) * | 2006-01-05 | 2014-10-16 | The Ohio State University Research Foundation | Métodos basados en microARN para el diagnóstico de cánceres de estómago |
| US20110034538A1 (en) | 2008-02-28 | 2011-02-10 | The Ohio State University Research Foundation | MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer |
| US9765334B2 (en) * | 2008-06-01 | 2017-09-19 | Rosetta Genomics, Ltd. | Compositions and methods for prognosis of gastric cancer |
| CN101988059B (zh) * | 2009-07-30 | 2014-04-02 | 江苏命码生物科技有限公司 | 胃癌检测标记物及其检测试剂盒和生物芯片 |
| WO2012010584A1 (en) * | 2010-07-20 | 2012-01-26 | Febit Holding Gmbh | Complex mirna sets as novel biomarkers for gastric cancer |
| US9939442B2 (en) * | 2011-09-08 | 2018-04-10 | The Regents Of The University Of California | Salivary biomarkers for gastric cancer detection |
| JP2013085542A (ja) * | 2011-10-21 | 2013-05-13 | Sysmex Corp | 胃癌の検出方法、胃癌の血液マーカーおよびその使用 |
| GB201317887D0 (en) * | 2013-10-09 | 2013-11-20 | Reneuron Ltd | Product |
| CN103773761B (zh) * | 2014-01-14 | 2016-01-20 | 南京医科大学 | 检测胃癌的血清/血浆微小rna标志物及其应用 |
| CN103937888B (zh) * | 2014-04-14 | 2016-08-17 | 上海交通大学 | 鉴别胃癌的血浆microRNA标志物的筛选与应用 |
| EP3177739B1 (en) * | 2014-08-07 | 2019-10-23 | Agency For Science, Technology And Research | Microrna biomarker for the diagnosis of gastric cancer |
-
2015
- 2015-08-11 EP EP15828973.6A patent/EP3177739B1/en active Active
- 2015-08-11 KR KR1020217009878A patent/KR102604163B1/ko active Active
- 2015-08-11 CN CN201580054452.0A patent/CN107109470B/zh active Active
- 2015-08-11 JP JP2017504739A patent/JP6702935B2/ja active Active
- 2015-08-11 WO PCT/SG2015/050256 patent/WO2016022076A1/en not_active Ceased
- 2015-08-11 KR KR1020177003456A patent/KR102237960B1/ko active Active
- 2015-08-11 US US15/501,691 patent/US10767230B2/en active Active
- 2015-08-11 SG SG10202011339RA patent/SG10202011339RA/en unknown
- 2015-08-11 SG SG11201700944RA patent/SG11201700944RA/en unknown
- 2015-08-11 EP EP19204522.7A patent/EP3744859B1/en active Active
- 2015-08-11 EP EP22187157.7A patent/EP4137586A1/en active Pending
-
2020
- 2020-05-07 JP JP2020081954A patent/JP7614735B2/ja active Active
-
2022
- 2022-09-12 JP JP2022144766A patent/JP7635186B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016022076A1 (en) | 2016-02-11 |
| JP7635186B2 (ja) | 2025-02-25 |
| CN107109470A (zh) | 2017-08-29 |
| JP6702935B2 (ja) | 2020-06-03 |
| EP3744859B1 (en) | 2025-05-07 |
| EP4137586A1 (en) | 2023-02-22 |
| KR20170035932A (ko) | 2017-03-31 |
| EP3177739A4 (en) | 2018-05-02 |
| JP2017525350A (ja) | 2017-09-07 |
| EP3177739A1 (en) | 2017-06-14 |
| JP2022188053A (ja) | 2022-12-20 |
| JP7614735B2 (ja) | 2025-01-16 |
| KR102604163B1 (ko) | 2023-11-20 |
| KR102237960B1 (ko) | 2021-04-08 |
| CN107109470B (zh) | 2020-09-15 |
| KR20210057079A (ko) | 2021-05-20 |
| EP3744859A3 (en) | 2021-03-17 |
| US20170233822A1 (en) | 2017-08-17 |
| US10767230B2 (en) | 2020-09-08 |
| EP3177739B1 (en) | 2019-10-23 |
| JP2020141684A (ja) | 2020-09-10 |
| SG11201700944RA (en) | 2017-03-30 |
| EP3744859A2 (en) | 2020-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201700944RA (en) | Microrna biomarker for the diagnosis of gastric cancer | |
| IL251560A0 (en) | Methods for preparing ribosides | |
| IL247273A0 (en) | Multispecific antibodies | |
| PL3227332T3 (pl) | Wielospecyficzne przeciwciała | |
| GB201414823D0 (en) | Multispecific antibodies | |
| LT3122358T (lt) | Egfr ir cmet inhibitorių deriniai, skirti vėžio gydymui | |
| SG11201606106SA (en) | Specific biomarker set for non-invasive diagnosis of liver cancer | |
| SG10201913528PA (en) | Methods of diagnosing cancer | |
| SG11201701076TA (en) | Diagnosis of cancer | |
| HUE057564T2 (hu) | Méhnyakrák biomarkerei | |
| PL3152576T3 (pl) | Zastosowanie tm9sf4 jako biomarkera egzosomów powiązanych z nowotworem | |
| GB201508480D0 (en) | Cancer | |
| GB201420239D0 (en) | Biomarker | |
| GB201416015D0 (en) | Biomarker | |
| IL247270A0 (en) | A method for detecting cancer | |
| EP3189332A4 (en) | Biomarkers for detection of breast cancer | |
| GB201410118D0 (en) | Early diagnosis of leptospire | |
| GB201400387D0 (en) | Diagnostic for gastric cancer | |
| GB201405060D0 (en) | Biomarkers for cancers of the digestive tract | |
| GB201405286D0 (en) | Cancer diagnostic | |
| GB201510419D0 (en) | Biomarkers for cancers of the digestive tract | |
| GB201414362D0 (en) | Biomarkers for early diagnosis of ovarian cancer | |
| GB201515253D0 (en) | Autoantibody biomarkers for gastric cancer | |
| AU2014901825A0 (en) | Biomarker of Disease | |
| GB201411343D0 (en) | Biomarker |